Martin Shkreli, the former hedge fund manager known as "Pharma Bro," defended Palantir Technologies Inc.'s valuation on Tuesday amid the company's surging stock price, projecting substantial cash flow ...

The company’s commercial revenue increased 64% in the quarter while U.S. government sales rose 45%. But if Wall Street ...

Palantir Technologies shares soared to an all-time high Tuesday after the company's outlook blew past analysts' expectations on strong demand for AI.

Morgan Stanley Wealth Management (MSWM) is seeing a stall in the S&P 500 ( SP500 ), and said the Federal Reserve halting its ...

Advanced Micro Devices’ (AMD) pre-market jump of nearly 2% on Tuesday reversed after Morgan Stanley lowered its price target ...

The software company has been on a record run, surging 340% in 2024 as its AI platform gained traction amid ongoing investor ...

The impressive fourth quarter earnings, which included a bottom-line beat of 14 cents per share and a gross profit margin of ...

Palantir shares soared over 18% due to increased demand for its AI-driven software and data analytics services. The company, involved with government and commercial clients, is capitalizing on the ...

Morgan Stanley has finally conceded that Palantir Technologies is not a stock to sell, but its analysts aren't quite ready to ...

SG Americas Securities LLC lowered its stake in shares of C3.ai, Inc. (NYSE:AI – Free Report) by 71.1% in the fourth quarter, ...